Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.96
-0.34 (-0.87%)
Jun 25, 2024, 2:59 PM EDT - Market open

CALT Revenue

In the year 2023, Calliditas Therapeutics AB (publ) had annual revenue of $119.73M with 55.09% growth.

Revenue (ttm)
$119.73M
Revenue Growth
+55.09%
P/S Ratio
8.72
Revenue / Employee
$546,717
Employees
219
Market Cap
1.04B USD

Revenue Chart

* The company reports in SEK currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023119.73M42.53M55.09%
Dec 31, 202277.20M51.72M202.95%
Dec 31, 202125.48M25.38M23,808.62%
Dec 31, 2020106.59K-19.77M-99.46%
Dec 31, 201919.87M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition